A clinical & scientific perspective on lecanemab – UK DRI Roundtable

Published 2022-12-16

Download video

Download video MP4 360p

Recommendations

36:22

A Closer Look at the Lecanemab Clinical Trials | Special Video Episode of Dementia Matters
59:20

What's Lecanemab and what's next?
1:12:58

Dopamine cell replacement therapies for Parkinson's:- Where are we now by Prof Roger Barker
58:53

Diversity & dementia: how is research bridging the health gap? A public webinar from the UK DRI
04:53

New drug brings hope to end Alzheimer's - BBC News
1:03:23

Understanding Lecanemab | Emory BrainTalk Live
58:00

Parkinson's Disease:- Red Light Therapy - Photobiomodulation
57:53

The harsh reality of ultra processed food - with Chris Van Tulleken
20:05

Dr. Paul Mason - 'The shady truth about statins'
04:30

The UK Dementia Research Institute: Five years of innovation in discovery science
13:12

Lecanemab: FDA Approved for Early Alzheimer's Disease
1:22:40

Parkinson's Disease:- "What if I discovered the Silver Bullet?" by Dr. Jonathan Sackner-Bernstein
03:43

Hope and anxiety surround new Alzheimer’s drug lecanemab
1:35:38

Making it Brain 2023 (Day 2): neuroscience research & career webinar for students from the UK DRI
06:01

The development of lecanemab & rationale behind its unique binding profile
14:06

Confronting Emptiness: Inside the World of Borderline Personality Disorder
15:50

Top 10 Most TOXIC Things For Your Body & How To Avoid Them
43:21

Parkinson's Disease :- Photobiomodulation (Red Light Therapy): A promising treatment
1:32:52

Making it Brain 2022 (Day 1): neuroscience research & career webinar for students from the UK DRI
14:28

Liz Parrish: Ageing is a Disease. Gene Therapy Could be the Cure | WIRED Health 2017 | WIRED Events

A clinical & scientific perspective on lecanemab – UK DRI Roundtable

Download video

Download video MP4 360p

A Closer Look at the Lecanemab Clinical Trials | Special Video Episode of Dementia Matters

What's Lecanemab and what's next?

Dopamine cell replacement therapies for Parkinson's:- Where are we now by Prof Roger Barker

Diversity & dementia: how is research bridging the health gap? A public webinar from the UK DRI

New drug brings hope to end Alzheimer's - BBC News

Understanding Lecanemab | Emory BrainTalk Live

Parkinson's Disease:- Red Light Therapy - Photobiomodulation

The harsh reality of ultra processed food - with Chris Van Tulleken

Dr. Paul Mason - 'The shady truth about statins'

The UK Dementia Research Institute: Five years of innovation in discovery science

Lecanemab: FDA Approved for Early Alzheimer's Disease

Parkinson's Disease:- "What if I discovered the Silver Bullet?" by Dr. Jonathan Sackner-Bernstein

Hope and anxiety surround new Alzheimer’s drug lecanemab

Making it Brain 2023 (Day 2): neuroscience research & career webinar for students from the UK DRI

The development of lecanemab & rationale behind its unique binding profile

Confronting Emptiness: Inside the World of Borderline Personality Disorder

Top 10 Most TOXIC Things For Your Body & How To Avoid Them

Parkinson's Disease :- Photobiomodulation (Red Light Therapy): A promising treatment

Making it Brain 2022 (Day 1): neuroscience research & career webinar for students from the UK DRI

Liz Parrish: Ageing is a Disease. Gene Therapy Could be the Cure | WIRED Health 2017 | WIRED Events

FDA approvals new Alzheimer's drug.

Lecanemab for Treatment of Early Alzheimer’s Disease: Overview & Clinician Perspectives

Putting Lecanemab into Practice: A Clinician’s Perspective on the New Alzheimer’s Treatment

Lecanemab - a breakthrough in treating Alzheimer´s disease?

BAN2401 (lecanemab) Mechanism of Action

Lecanemab and what this means for the future treatment of Alzheimer’s disease

Lecanemab for Alzheimer’s Disease: A New Hope to Slow Memory Loss

Drug Development Roundtable

Introducing Lecanemab, the Latest Alzheimer’s Disease Drug to Receive FDA Accelerated Approval

Leqembi Vs Donanemab: Cure for Alzheimer's?

Lecanemab shows potential as treatment for Alzheimer

The New Alzheimer’s Drug: What is Leqembi?

Lecanemab: a review

Monoclonal Antibodies Targeting Amyloid for Alzheimer Disease

Leqembi Webinar Sept 2023